ODTX (Odyssey Therapeutics, Inc. Common Stock) Stock Analysis - Financials

Odyssey Therapeutics, Inc. Common Stock (ODTX) is a publicly traded the market company. As of May 21, 2026, ODTX trades at $16.98 with a market cap of $820.36M and a P/E ratio of 0.00. ODTX moved +0.35% today. Year to date, ODTX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $15.35 to $20.30. Rallies surfaces ODTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ODTX's key financials?

ODTX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ODTX recently traded at $16.98. Market cap is $820.36M. P/E ratio is 0.00. Revenue is $0.

ODTX Key Metrics

Key financial metrics for ODTX
MetricValue
Price$16.98
Market Cap$820.36M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$20.30
52-Week Low$15.35
Volume144
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ODTX News

Recent ODTX Insider Trades

  • TPG GP A, LLC bought 1.39M (~$25.00M) on May 11, 2026.
  • SR ONE CAPITAL MANAGEMENT, LLC sold 1.06K (~$19.17K) on May 11, 2026.
  • SR ONE CAPITAL MANAGEMENT, LLC bought 222.22K (~$4.00M) on May 11, 2026.

ODTX Analyst Consensus

ODTX analyst coverage data. Average price target: $0.00.

Common questions about ODTX

What are ODTX's key financials?
ODTX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ODTX recently traded at $16.98. Market cap is $820.36M. P/E ratio is 0.00. Revenue is $0.
Is ODTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ODTX. It does not provide personalized investment advice.
ODTX

ODTX